Please wait...
GulfBase Live Support
- Picking UAE stocks that can withstand global markets' tariff whiplash
- Dubai's Emirates NBD clears Dh1 trillion balance-sheet milestone in Q1-2025
- NBK reports a net profit of KD 134.1 million for Q1 2025
- CBB Treasury Bills oversubscribed by 166%
- Bahrain All Share Index closes lower
- Boubyan Bank records KD 26.5 million in net profit for Q1, 2025, an increase of 6%
- Zain Kuwait, one of the first mobile operators in region to achieve ISO 37301
- CBO launches 74th issue of Government Development Bonds via auction
- QNB Group broadens funding sources, open to future opportunities
- Bank Muscat advances digital transformation
- :Muscat Securities Market
- :Not Listed
- :Micro Cap
- :Health Care
Company Overview
- :14/02/1996
- :OMR 5,000,000
- :OMR 00
Activities
National Pharmaceutical Industries Company (NPMI) is a public company, based in Muscat (Oman), and established in February 1996. NPMI is a subsidiary of Oman Investment Fund Holding Co. and is listed on the Muscat Securities Market since January 2005. The company specializes in the production of anti-allergic, anti-inflammatory, antidepressant,and anti-diabetic medications, and also gastrointestinal drugs. It is among the first pharmaceutical formulations manufacturing plant in Sultanate of Oman. It offers lipid lowering, cardio vascular, anti-bacterial, anti-allergic, non-steroidal anti-inflammatory, gastro intestinal, anti-diabetic, anti-depressant, and analgesic anti-pyretic products too. The company also operates worldwide in almost 12 countries and has a business base in the Gulf and Middle East counties for almost a decade. The company's facilities are spread over a 30,042.43 square meters plot of land, and includes a non-beta lactum plant for producing oral solids, liquids, drops, dry suspensions and sachets; a beta lactum plant, which engages in production of capsules and dry suspension; a research and development laboratory, and a quality control laboratory.
-
Chairman:Ghazi O. Al Zubeidi
-
Vice-chairman:Abdullah M. B. Al Qenaei
-
CEO:G . Sridhar
-
General Manager:
-
Managing Director:
-
Board Members:
Amal S. Bahwan
Khalifa S. Al Mohannadi
Mahmoud A. Zubaid
Omar S. Bahwan
-
Auditors:
Moore Stephens
National Pharmaceutical Industries Company plans to raise its capital by OMR5 million by way of a ...
Read More ...| Announced On | Period | As Of | Net Profit (SAR Mil) | Growth (%) |
|---|---|---|---|---|
| 15/10/2018 | 9-Month | 30/09/2018 | 01 | 25 |
| 12/04/2018 | 3-Month | 31/03/2018 | 00 | 16.39 |
| 14/01/2018 | 12-Month | 31/12/2017 | 02 | 21.33 |
| 12/10/2017 | 9-Month | 30/09/2017 | 01 | 7.05 |
| 12/07/2017 | 6-Month | 30/06/2017 | 01 | -9.96 |
- info@npioman.com
- www.npioman.com
- P.O. Box 120, Rusayl 124
| Market Cap US$ Mil |
Last Price Local Cry |
Price Change (%) 1 Day |
Price Change (%) 1 Year |
P/E TTM | P/B MRQ | Dividend Yield (%) | Beta | ROA (%) | ROE (%) | |
|---|---|---|---|---|---|---|---|---|---|---|
| SULAIMANALHABIB | 26,303.55 | 283 | 0.35 | -2.58 | 44.33 | 0 | 0 | 0 | 0 | 0 |
| PUREHEALTH | 8,045.02 | 2.66 | 0 | 0 | 26.31 | 0 | 0 | 0 | 0 | 0 |
| ARMAH | 7,784.93 | 88 | -1.02 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| MOUWASAT | 3,960.19 | 73.4 | -1.22 | -28.46 | 22.58 | 2.67 | 0 | 0.81 | 13.85 | 22.49 |
| NAHDI | 3,949.53 | 113.8 | -0.18 | -15.6 | 17.78 | 0 | 0 | 0 | 0 | 0 |
| DALLAHHEALTH | 3,326.89 | 126 | -1.41 | -5.63 | 26.51 | 4.64 | 0 | 0.93 | 12.1 | 17.53 |
| FAKEEHCARE | 2,881.18 | 46 | -1.29 | 0 | 40.15 | 0 | 0 | 0 | 0 | 0 |
| JAMJOOMPHARMA | 2,869.14 | 154.2 | 0.26 | 18.09 | 30.81 | 0 | 0 | 0 | 0 | 0 |
| AME | 2,234.87 | 116.6 | -2.68 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| NABAALSAHA | 1,849.64 | 65.1 | -1.52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CARE | 1,757.02 | 145 | -1.37 | -16.19 | 24.02 | 6.83 | 0 | 0.85 | -0.59 | -0.89 |
| TIBBIYAH | 1,753.57 | 32.9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SAUDIGERMANHEALTH | 1,616.44 | 64.7 | -1.83 | -28.25 | 28.7 | 3.72 | 0 | 0.79 | 11.92 | 18.76 |
| QOMEL | 1,117.43 | 61.1 | -49 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PROMEDEX | 923.42 | 100 | 1.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SPIMACO | 789.91 | 24.66 | -0.17 | -2.21 | 73.21 | 1.12 | 0 | 0.91 | 8.47 | 15.11 |
| ALMUJTAMAMEDICAL | 734.21 | 29 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| AVALONPHARMA | 688.64 | 128.4 | -0.62 | 0 | 32.12 | 0 | 0 | 0 | 0 | 0 |
| MIRAL | 638.53 | 119 | -0.67 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| MIDAN | 529.53 | 797 | 0 | -4.78 | 13.35 | 1.39 | 0 | 0 | 12.06 | 17.87 |
| AYYAN | 422.14 | 15.6 | -0.89 | -8.1 | -7.52 | 1.58 | 0 | 0.81 | -2 | -2.64 |
| JULPHAR | 402.5 | 1.27 | -0.79 | 0 | -64.32 | 0.62 | 5.27 | 0.2 | 4.09 | 0 |
| GMPC | 380.49 | 1.93 | -3.5 | 0 | 0 | 1.06 | 3 | -0.08 | 75.81 | 111.42 |
| ATC.KW | 374.03 | 760 | 0 | 0 | 41.83 | 2.31 | 1.82 | -0.01 | 2.93 | 12.88 |
| MCGS | 356.36 | 4.66 | 0.21 | -0.04 | 21.79 | 0.13 | 5.86 | 0.98 | 6.76 | 7.99 |
| EQUIPMENTHOUSE | 327 | 39.95 | -2.33 | 5.1 | 25.51 | 0 | 0 | 0 | 0 | 0 |
| LANA | 288.3 | 30.05 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| TMC | 243.05 | 21.52 | -5.62 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| RPM | 219.39 | 3.97 | -1.49 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| BURJEEL | 204.02 | 1.44 | 0 | 0 | 1.6 | 0 | 0 | 0 | 0 | 0 |
| CMCER | 126.41 | 6.16 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| ALMODAWAT | 113.55 | 17.82 | -0.67 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| FUTURECARE | 86.35 | 6.34 | -2.17 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| QGMD | 42.46 | 1.35 | 0 | 16.69 | -2.28 | 0.23 | 0 | 0.76 | -6.18 | 0 |
| SMILECARE | 30.81 | 5.72 | -1.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| BALSMMEDICAL | 24.98 | 74.1 | -1.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| ALRAZI | 19.65 | 49 | 1.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| JANA | 16.39 | 18.48 | -3.45 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Financial Information Co.
P.O. Box 69410, Jeddah 11547, Saudi Arabia